Articles by Geneviève Chêne

1 2 3 4 5

Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome

Chakrabarti, Lisa A.; Boucherie, Céline; Bugault, Florence; More

AIDS. 28(11):1593-1602, July 17th, 2014.

Decline in locomotor functions over time in HIV-infected patients

Richert, Laura; Brault, Mathilde; Mercié, Patrick; More

AIDS. 28(10):1441-1449, June 19th, 2014.

Transmitted drug resistance in French HIV-2-infected patients

Charpentier, Charlotte; Visseaux, Benoit; Bénard, Antoine; More

AIDS. 27(10):1671-1674, June 19th, 2013.

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Richert, Laura; Hue, Sophie; Hocini, Hakim; More

AIDS. 27(9):1421-1431, June 1st, 2013.

Cognitive disorders in HIV-infected patients: are they HIV-related?

Bonnet, Fabrice; Amieva, Hélène; Marquant, Fabienne; More

AIDS. 27(3):391-400, January 28th, 2013.

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

Visseaux, Benoit; Charpentier, Charlotte; Taieb, Audrey; More

AIDS. 27(2):292-295, January 14th, 2013.

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

Lévy, Yves; Thiébaut, Rodolphe; Gougeon, Marie-Lise; More

AIDS. 26(6):711-720, March 27th, 2012.

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

Capeau, Jacqueline; Bouteloup, Vincent; Katlama, Christine; More

AIDS. 26(3):303-314, January 28th, 2012.

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007

van der Helm, Jannie J; Prins, Maria; del Amo, Julia; More

AIDS. 25(8):1083-1091, May 15th, 2011.

Reply to comment on ‘pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients’

Barrail-Tran, Aurélie; Yazdanpanah, Yazdan; Goldwirt, Lauriane; More

AIDS. 25(7):1011-1012, April 24th, 2011.

High frequency of poor locomotor performance in HIV-infected patients

Richert, Laura; Dehail, Patrick; Mercié, Patrick; More

AIDS. 25(6):797-805, March 27th, 2011.

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen

Charpentier, Charlotte; Roquebert, Bénédicte; Colin, Céline; More

AIDS. 24(17):2651-2656, November 13th, 2010.

CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era

Lodi, Sara; Phillips, Andrew; Touloumi, Giota; More

AIDS. 24(17):2697-2704, November 13th, 2010.

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572

Charpentier, Charlotte; Larrouy, Lucile; Collin, Gilles; More

AIDS. 24(17):2753-2755, November 13th, 2010.

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients

Barrail-Tran, Aurélie; Yazdanpanah, Yazdan; Goldwirt, Lauriane; More

AIDS. 24(16):2581-2583, October 23, 2010.

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

Marin, Benoît; Thiébaut, Rodolphe; Bucher, Heiner C; More

AIDS. 23(13):1743-1753, August 24th, 2009.

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

Viard, Jean-Paul; Fagard, Catherine; Chaix, Marie-Laure; More

AIDS. 23(11):1383-1388, July 17th, 2009.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

Bénard, Antoine; Damond, Florence; Campa, Pauline; More

AIDS. 23(9):1171-1173, June 1st, 2009.

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults

Collin, Fidéline; Duval, Xavier; Le Moing, Vincent; More

AIDS. 23(8):1021-1024, May 15th, 2009.

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

Drylewicz, Julia; Matheron, Sophie; Lazaro, Estibaliz; More

AIDS. 22(4):457-468, February 19th, 2008.

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

Lesprit, Philippe; Pédrono, Gaëlle; Molina, Jean-Michel; More

AIDS. 21(18):2425-2434, November 30th, 2007.

Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results

Raguin, Gilles; Poizat, Gwendoline; Morand-Joubert, Laurence; More

AIDS. 21(2):241-243, January 11th, 2007.

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

Lortholary, Olivier; Poizat, Gwendoline; Zeller, Valérie; More

AIDS. 20(17):2183-2191, November 14th, 2006.

No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

Descamps, Diane; Damond, Florence; Bénard, Antoine; More

AIDS. 20(7):1076-1079, April 24th, 2006.

Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 × 106 cells/l

Thiébaut, Rodolphe; Pellegrin, Isabelle; Chêne, Geneviève; More

AIDS. 19(1):53-61, January 3rd, 2005.

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

Rancinan, Corinne; Neau, Didier; Savès, Marianne; More

AIDS. 16(10):1357-1362, July 5th, 2002.

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

Le Moing, Vincent; Chêne, Geneviève; Carrieri, Maria P.; More

AIDS. 16(1):21-29, January 4th, 2002.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

Jouan, Marc; Savès, Marianne; Tubiana, Roland; More

AIDS. 15(1):23-31, January 5th, 2001.

Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment

Thiébaut, Rodolphe; Morlat, Philippe; Jacqmin-Gadda, Hélène; More

AIDS. 14(8):971-978, May 26th, 2000.

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment

Chêne, Geneviève; Binquet, Christine; Moreau, Jean-François; More

AIDS. 12(17):2313-2320, November 1998.

Predictive value ofToxoplasma gondiiantibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients

Derouin, Francis; Leport, Catherine; Pueyo, Sophie; More

AIDS. 10(13):1521-1527, November 1996.

1 2 3 4 5